SEC Form 4/A · accession 0001179110-19-000404
CATABASIS PHARMACEUTICALS INC · CATB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Anthony Gregg Lapointe
Director
Period of report
Jan 3, 2019
Accepted (ET)
Jan 4, 2019 · 4:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001454789
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $4.60 | Jan 3, 2019 | A | 2,800 | A | — | Jan 2, 2029 | Common Stock | 2,800 | 2,800 | D |
Explanation of responses
- F1This 4/A is being filed to correct the stated Conversion or Exercise Price of Derivative Security. The correct Exercise Price of the Derivative Security is $4.60 and was previously stated at $4.90.
- F2This option was granted on January 3, 2019. The option is scheduled to vest as to one-third of the shares of common stock underlying the option on each anniversary of the grant date until the third anniversary of the grant date.